EIKONIZO THERAPEUTICS Trademark

Trademark Overview


On Tuesday, June 1, 2021, a trademark application was filed for EIKONIZO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EIKONIZO THERAPEUTICS trademark a serial number of 90747075. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, April 24, 2025. This trademark is owned by Eikonizo Therapeutics, Inc.. The EIKONIZO THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; diagnostic agents, preparati...
eikonizo therapeutics

General Information


Serial Number90747075
Word MarkEIKONIZO THERAPEUTICS
Filing DateTuesday, June 1, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, April 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and ServicesPharmaceutical, therapeutic and biopharmaceutical agents for the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances or the treatment of neurodegenerative and neurological diseases, namely, amyotrophic lateral sclerosis (ALS), Alzheimer's Disease (AD), and chemotherapy-induced peripheral neuropathy (CIPN), treatments in oncology, namely, chemotherapy-induced peripheral neuropathy (CIPN), treatments in nephrology, namely, autosomal dominant polycyclic kidney disease (ADPKD), and treatments in cardiology, namely, cardiac diseases; diagnostic agents, preparations, substances and diagnostic materials in the form of preparations for medical purposes; imaging agents for positron emission tomography (PET) imaging for delivery of materials to target sites within the body for diagnostic purposes; imaging agents for positron emission tomography (PET) imaging for use in detecting disease, namely, radio tracers for positron emission tomography (PET) imaging
Translation of Words in MarkThe English translation of "EIKONIZO" in the mark is "ENVISAGE".
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEikonizo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameEikonizo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Friday, February 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 15, 2022ASSIGNED TO EXAMINER
Friday, February 25, 2022NON-FINAL ACTION WRITTEN
Friday, February 25, 2022NON-FINAL ACTION E-MAILED
Thursday, August 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 5, 2022ASSIGNED TO LIE
Thursday, October 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 26, 2022FINAL REFUSAL WRITTEN
Wednesday, October 26, 2022FINAL REFUSAL E-MAILED
Wednesday, October 26, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 26, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 26, 2023EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, April 26, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, April 26, 2023EX PARTE APPEAL-INSTITUTED
Thursday, April 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 11, 2024EXPARTE APPEAL TERMINATED
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 9, 2025SOU EXTENSION 1 FILED
Thursday, January 9, 2025DIVISIONAL REQUEST RECEIVED
Thursday, January 9, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 9, 2025TEAS REQUEST TO DIVIDE RECEIVED
Thursday, April 17, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 24, 2025SOU EXTENSION 1 GRANTED
Thursday, April 24, 2025DIVISIONAL PROCESSING COMPLETE
Friday, April 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED